TMO Thermo Fisher Scientific Inc

  1. Stocks
  2. Healthcare
  3. NYSE: TMO

Price (delayed)

$607.14

Market cap

$231.76B

P/E Ratio

38.79

Dividend/share

$1.48

EPS

$15.65

Enterprise value

$261.86B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry . ...

Highlights
Thermo Fisher Scientific's quick ratio has soared by 51% YoY but it has decreased by 6% from the previous quarter
The company's equity rose by 8% YoY but it fell by 2.6% QoQ
The stock's price to earnings (P/E) is 23% more than its 5-year quarterly average of 31.6 and 11% more than its last 4 quarters average of 34.9
Thermo Fisher Scientific's revenue has decreased by 3% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.thermofisher.com/
Peers: BDX WAT BIO ISRG

Key stats

What are the main financial stats of TMO
Market
Shares outstanding
381.72M
Market cap
$231.76B
Enterprise value
$261.86B
Valuations
Price to earnings (P/E)
38.79
Price to book (P/B)
5.09
Price to sales (P/S)
5.46
EV/EBIT
32.77
EV/EBITDA
23.02
EV/Sales
6.16
Earnings
Revenue
$42.49B
EBIT
$7.99B
EBITDA
$11.37B
Free cash flow
$7.65B
Per share
EPS
$15.65
Free cash flow per share
$20.01
Book value per share
$119.37
Revenue per share
$111.24
TBVPS
$97.39
Balance sheet
Total assets
$97.1B
Total liabilities
$51.59B
Debt
$35.61B
Equity
$45.52B
Working capital
$9.7B
Liquidity
Debt to equity
0.78
Current ratio
1.7
Quick ratio
1.09
Net debt/EBITDA
2.65
Margins
EBITDA margin
26.8%
Gross margin
40.4%
Net margin
14.2%
Operating margin
16.4%
Efficiency
Return on assets
6.2%
Return on equity
13.3%
Return on invested capital
15.5%
Return on capital employed
9.6%
Return on sales
18.8%
Dividend
Dividend yield
0.24%
DPS
$1.48
Payout ratio
9.5%

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time
Intraday
2.13%
1 week
13.62%
1 month
8.77%
1 year
5.7%
YTD
14.38%
QTD
9.79%

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$42.49B
Gross profit
$17.17B
Operating income
$6.96B
Net income
$6.03B
Gross margin
40.4%
Net margin
14.2%
Thermo Fisher Scientific's revenue has decreased by 3% YoY
Thermo Fisher Scientific's gross profit has decreased by 2.7% YoY
The net margin has increased by 2.9% YoY
Thermo Fisher Scientific's operating margin has increased by 2.5% from the previous quarter

Growth

What is Thermo Fisher Scientific's growth rate over time

Valuation

What is Thermo Fisher Scientific stock price valuation
TMO P/E details
P/E
38.79
P/B
5.09
P/S
5.46
EV/EBIT
32.77
EV/EBITDA
23.02
EV/Sales
6.16
The stock's price to earnings (P/E) is 23% more than its 5-year quarterly average of 31.6 and 11% more than its last 4 quarters average of 34.9
The P/B is 13% above the last 4 quarters average of 4.5 and 3.9% above the 5-year quarterly average of 4.9
The company's equity rose by 8% YoY but it fell by 2.6% QoQ
The P/S is 14% above the last 4 quarters average of 4.8 and 7% above the 5-year quarterly average of 5.1
Thermo Fisher Scientific's revenue has decreased by 3% YoY

Efficiency

How efficient is Thermo Fisher Scientific business performance
TMO's ROS is up by 12% year-on-year and by 5% since the previous quarter
The ROE has contracted by 5% YoY
TMO's ROA is down by 4.6% YoY

Dividends

What is TMO's dividend history
Dividend details
DPS
$1.48
Dividend yield
0.24%
Payout ratio
9.5%
Recent dividends

Financial health

How did Thermo Fisher Scientific financials performed over time
The total assets is 88% greater than the total liabilities
Thermo Fisher Scientific's quick ratio has soared by 51% YoY but it has decreased by 6% from the previous quarter
The current ratio has increased by 34% year-on-year but it has declined by 2.9% since the previous quarter
The debt is 22% lower than the equity
The company's equity rose by 8% YoY but it fell by 2.6% QoQ
Thermo Fisher Scientific's debt to equity has decreased by 6% YoY but it has increased by 4% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.